FS Arzneimittelindustrie e.V.

Dr. Holger Diener - Geschäftsführer
Daniela von Arnim - Assistentin

Grolmanstr. 44-45
10623 Berlin

d.arnim@fsa-pharma.de
Tel.: 030 88728-1700
Fax: 030 88728-1705

Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.

Advantages

For physicians

The overriding principle of FSA member companies is transparency. This means that there are clear rules for collaboration with healthcare professionals. This results in clear advantages for physicians:

  • Physicians need not do without the information and further training offered by the pharmaceutical industry, as this is solely based on objective scientific criteria.
  • For physicians, the FSA rules mean a strengthening of their work and the preservation of physician independence and freedom of therapy.
  • Physicians can be assured that they will receive scientifically based information that is vital for their practical therapy, thus serving the well-being of the patient.
  • Through transparency in collaboration, the appearance of conflicts of interest can be prevented at the onset.

For patients

Trust is the pillar of every physician-patient relationship. Through transparency in the collaboration among stakeholders in the healthcare field, the patient can be assured that any therapy prescribed by the physician will be useful and geared towards his well-being and not driven by economic interests.

  • Companies that have submitted to the FSA Codes have agreed to not influence the physician's freedom of procurement, therapy and decision-making in unethical ways.
  • With the disclosure of payments by pharmaceutical companies to healthcare professionals, patients have the opportunity to independently verify that there is ethically sound collaboration.
  • In the future, patients can review which physician is cooperating with which company, and for what purpose.

For the public

Public expectations concerning transparency of the system are ever increasing. In the public eye, the plausibility of all cooperation in the healthcare field is a topic under close scrutiny. The FSA Transparency Code addresses this trend.

  • Through the publishing of payments, the nature and scope of the cooperation of pharmaceutical companies with healthcare professionals are rendered even more transparent.
  • In the future, everyone will be able to understand why a particular physician has entered into a working relationship with a certain company.
  • The FSA, its member companies and the physicians cooperating with them, are thus heeding the public call for more transparency.

    The FSA

    Information on the „Freiwillige Selbstkontrolle für die Arzneimittelindustrie e. V.“ (FSA) is available at

    www.fsa-pharma.de.

    Current News

    New Press Release: Research-based pharmaceutical companies implement Transparency Code

    more

    The International Olympic Committee published its indemnity policy for the first time to increase transparency within the organization

    more

    Allergo Journal "wholeheartedly" supports the transparency initiative of the FSA

    more

    Survey: Most Physicians Report Being Unaffected By Open Payments Database.

    more

    Disclosure of payments to health professionals: Going Live

    more

    Press Contact

    wbpr_ Kommunikation
    Natalie Schneider
    Phone: +49 89/99 59 06-25
    Email: natalie.schneider@wbpr.de